Home About us Reports Charts News Custom Company Scan  
Report Charts News
Title Content
Life Sciences
  Metals & Minerals
Public Sector
  Finance Service
  Real Estate
Technology And Media

Tel: 0086-10-82600828
Fax: 0086-10-82601570

 Guangji Pharma sold its subsidiary Jifeng Industry Co for RMB 60mln to revive financial performance
CreateTime:2013-12-16 Editor:liaoyan
Text Size:       

Hubei Guangji Pharmaceutical Co.,Ltd. sold nearly half its share of Hubei Jifeng Industry Co for RMB 60 million. If the stock transfer procedure can be completed by the end of the year, Guangji Pharma could finish this year with over RMB 20 million revenue after 2 years deficit. 

As a public listed company, Guangji Pharma has experienced deficit for 2 years. After stripping of the assets and receiving various government subsidies, Guangji Pharma is highly possible to be earning this year.

Related Reports
China Blood Product Industry Report, 2020-2027
China Medical Robot Industry Report, 2020-2026
China In Vitro Diagnostic (IVD) Industry Report, 2019-2025
China Aged Care Industry Report, 2019-2025
China Dental Industry Report, 2019-2025
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1